Similar articles

• Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

  Boursier J, de Ledinghen V, Zarski JP, Fouchard-Hubert I, Gallois Y, Oberti F, Calès P; multicentric groups from SNIFF 32, VINDIAG 7, and ANRS/HC/EP23 FIBROSTAR studies. Boursier J, et al. Hepatology. 2012 Jan;55(1):58-67. doi: 10.1002/hep.24654. Hepatology. 2012. PMID: 21898504
• Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.

  Castéra L, Sebastiani G, Le Bail B, de Lédinghen V, Couzigou P, Alberti A. Castéra L, et al. J Hepatol. 2010 Feb;52(2):191-8. doi: 10.1016/j.jhep.2009.11.008. Epub 2009 Nov 24. J Hepatol. 2010. PMID: 20006397
• Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.

  Sebastiani G, Halfon P, Castera L, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. Sebastiani G, et al. Aliment Pharmacol Ther. 2012 Jan;35(1):92-104. doi: 10.1111/j.1365-2036.2011.04897.x. Epub 2011 Oct 28. Aliment Pharmacol Ther. 2012. PMID: 22035045
• Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis.

  Afdhal NH, Curry M. Afdhal NH, et al. J Hepatol. 2007 Apr;46(4):543-5. doi: 10.1016/j.jhep.2007.01.008. Epub 2007 Jan 29. J Hepatol. 2007. PMID: 17316879 Review. No abstract available.
• Staging of liver disease: which option is right for my patient?

  Bhogal H, Sterling RK. Bhogal H, et al. Infect Dis Clin North Am. 2012 Dec;26(4):849-61. doi: 10.1016/j.idc.2012.08.002. Infect Dis Clin North Am. 2012. PMID: 23083819 Review.